International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics

Hermann AM Mucke, Peter Mucke, Eva MuckeHM Pharma Consultancy, Vienna, AustriaAbstract: While investigative ophthalmologists access peer-reviewed journals as part of their daily routine, and while they regularly visit scientific congresses, they rarely peruse patent documents as an information sourc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hermann AM Mucke, Peter Mucke, Eva Mucke
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/e822b495dd4c4c2b9ab5abd1bbe36a21
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e822b495dd4c4c2b9ab5abd1bbe36a21
record_format dspace
spelling oai:doaj.org-article:e822b495dd4c4c2b9ab5abd1bbe36a212021-12-02T03:10:08ZInternational patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics1177-54671177-5483https://doaj.org/article/e822b495dd4c4c2b9ab5abd1bbe36a212008-10-01T00:00:00Zhttp://www.dovepress.com/international-patenting-in-ophthalmology-an-analysis-of-its-structure--a2517https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Hermann AM Mucke, Peter Mucke, Eva MuckeHM Pharma Consultancy, Vienna, AustriaAbstract: While investigative ophthalmologists access peer-reviewed journals as part of their daily routine, and while they regularly visit scientific congresses, they rarely peruse patent documents as an information source. Among the reasons for this negligence are the incompatibility of patent search algorithms with those known from journal databases, a legalistic and frequently redundant language, and misconceptions about the nature of the patenting system. Here we present key data and analyses from the ophthalmology module of a patent database system that we are developing to address some of these problems. We show that international patent applications consistently reflect developer interest in the ocular drug and diagnostics field; that they are technically focused lead indicators of developments that frequently feature in peer-reviewed patenting only much later; and that patenting targets are well aligned with the unmet therapeutic needs of populations in industrialized countries. Most applications (74%–78% in years since 2006) are supported with experimental data, and most (on average, 80%–90%) faced at least one objection to patentability during their initial stage of examination. In contrast to the peer-reviewed scenery that is highly diverse, the corresponding patenting arena shows a pronounced focus on the United States.Keywords: ophthalmology, eye diseases, iontophoresis, intellectual property, patents as topic, bibliographic databases Hermann AM MuckePeter MuckeEva MuckeDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2009, Iss default, Pp 103-109 (2008)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Hermann AM Mucke
Peter Mucke
Eva Mucke
International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics
description Hermann AM Mucke, Peter Mucke, Eva MuckeHM Pharma Consultancy, Vienna, AustriaAbstract: While investigative ophthalmologists access peer-reviewed journals as part of their daily routine, and while they regularly visit scientific congresses, they rarely peruse patent documents as an information source. Among the reasons for this negligence are the incompatibility of patent search algorithms with those known from journal databases, a legalistic and frequently redundant language, and misconceptions about the nature of the patenting system. Here we present key data and analyses from the ophthalmology module of a patent database system that we are developing to address some of these problems. We show that international patent applications consistently reflect developer interest in the ocular drug and diagnostics field; that they are technically focused lead indicators of developments that frequently feature in peer-reviewed patenting only much later; and that patenting targets are well aligned with the unmet therapeutic needs of populations in industrialized countries. Most applications (74%–78% in years since 2006) are supported with experimental data, and most (on average, 80%–90%) faced at least one objection to patentability during their initial stage of examination. In contrast to the peer-reviewed scenery that is highly diverse, the corresponding patenting arena shows a pronounced focus on the United States.Keywords: ophthalmology, eye diseases, iontophoresis, intellectual property, patents as topic, bibliographic databases
format article
author Hermann AM Mucke
Peter Mucke
Eva Mucke
author_facet Hermann AM Mucke
Peter Mucke
Eva Mucke
author_sort Hermann AM Mucke
title International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics
title_short International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics
title_full International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics
title_fullStr International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics
title_full_unstemmed International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics
title_sort international patenting in ophthalmology: an analysis of its structure and relevance for the development of drugs and diagnostics
publisher Dove Medical Press
publishDate 2008
url https://doaj.org/article/e822b495dd4c4c2b9ab5abd1bbe36a21
work_keys_str_mv AT hermannammucke internationalpatentinginophthalmologyananalysisofitsstructureandrelevanceforthedevelopmentofdrugsanddiagnostics
AT petermucke internationalpatentinginophthalmologyananalysisofitsstructureandrelevanceforthedevelopmentofdrugsanddiagnostics
AT evamucke internationalpatentinginophthalmologyananalysisofitsstructureandrelevanceforthedevelopmentofdrugsanddiagnostics
_version_ 1718401952033800192